77 related articles for article (PubMed ID: 22998750)
1. Does the small tyrosine kinase inhibitor Imatinib mesylate counteract diabetes by affecting pancreatic islet amyloidosis and fibrosis?
Welsh N
Expert Opin Investig Drugs; 2012 Nov; 21(11):1743-50. PubMed ID: 22998750
[TBL] [Abstract][Full Text] [Related]
2. Amelioration of diabetes by imatinib mesylate (Gleevec): role of beta-cell NF-kappaB activation and anti-apoptotic preconditioning.
Hägerkvist R; Sandler S; Mokhtari D; Welsh N
FASEB J; 2007 Feb; 21(2):618-28. PubMed ID: 17135364
[TBL] [Abstract][Full Text] [Related]
3. Imatinib mesylate (Gleevec) protects against streptozotocin-induced diabetes and islet cell death in vitro.
Hägerkvist R; Makeeva N; Elliman S; Welsh N
Cell Biol Int; 2006 Dec; 30(12):1013-7. PubMed ID: 17020808
[TBL] [Abstract][Full Text] [Related]
4. Are off-target effects of imatinib the key to improving beta-cell function in diabetes?
Welsh N
Ups J Med Sci; 2022; 127():. PubMed ID: 36187072
[TBL] [Abstract][Full Text] [Related]
5. Islet amyloid and type 2 diabetes mellitus.
Höppener JW; Ahrén B; Lips CJ
N Engl J Med; 2000 Aug; 343(6):411-9. PubMed ID: 10933741
[No Abstract] [Full Text] [Related]
6. Potential utility of small tyrosine kinase inhibitors in the treatment of diabetes.
Mokhtari D; Welsh N
Clin Sci (Lond); 2009 Nov; 118(4):241-7. PubMed ID: 19886867
[TBL] [Abstract][Full Text] [Related]
7. Amyloidosis of pancreatic islets in primary amyloidosis (AL type).
Tomita T
Pathol Int; 2005 Apr; 55(4):223-7. PubMed ID: 15826250
[TBL] [Abstract][Full Text] [Related]
8. Imatinib mesylate attenuates fibrosis in coxsackievirus b3-induced chronic myocarditis.
Leipner C; Grün K; Müller A; Buchdunger E; Borsi L; Kosmehl H; Berndt A; Janik T; Uecker A; Kiehntopf M; Böhmer FD
Cardiovasc Res; 2008 Jul; 79(1):118-26. PubMed ID: 18326555
[TBL] [Abstract][Full Text] [Related]
9. Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis.
Distler JH; Jüngel A; Huber LC; Schulze-Horsel U; Zwerina J; Gay RE; Michel BA; Hauser T; Schett G; Gay S; Distler O
Arthritis Rheum; 2007 Jan; 56(1):311-22. PubMed ID: 17195235
[TBL] [Abstract][Full Text] [Related]
10. [Amylin and amyloidosis of the pancreatic islets and their significance in the etiology and pathogenesis of diabetes mellitus type 2].
Kamaeva OI
Ter Arkh; 1993; 65(10):14-7. PubMed ID: 8296225
[No Abstract] [Full Text] [Related]
11. Imatinib ameliorates fibrosis in uraemic cardiac disease in BALB/c without improving cardiac function.
Baumann M; Leineweber K; Tewiele M; Wu K; Türk TR; Su S; Gössl M; Buck T; Wilde B; Heemann U; Kribben A; Witzke O
Nephrol Dial Transplant; 2010 Jun; 25(6):1817-24. PubMed ID: 20061323
[TBL] [Abstract][Full Text] [Related]
12. A feline model of experimentally induced islet amyloidosis.
Hoenig M; Hall G; Ferguson D; Jordan K; Henson M; Johnson K; O'Brien T
Am J Pathol; 2000 Dec; 157(6):2143-50. PubMed ID: 11106586
[TBL] [Abstract][Full Text] [Related]
13. Diabetes mellitus in cystic fibrosis is characterized by islet amyloidosis.
Couce M; O'Brien TD; Moran A; Roche PC; Butler PC
J Clin Endocrinol Metab; 1996 Mar; 81(3):1267-72. PubMed ID: 8772610
[TBL] [Abstract][Full Text] [Related]
14. Role of islet amyloid in type 2 diabetes mellitus.
Höppener JW; Lips CJ
Int J Biochem Cell Biol; 2006; 38(5-6):726-36. PubMed ID: 16459127
[TBL] [Abstract][Full Text] [Related]
15. Imatinib attenuates severe mouse dystrophy and inhibits proliferation and fibrosis-marker expression in muscle mesenchymal progenitors.
Ito T; Ogawa R; Uezumi A; Ohtani T; Watanabe Y; Tsujikawa K; Miyagoe-Suzuki Y; Takeda S; Yamamoto H; Fukada S
Neuromuscul Disord; 2013 Apr; 23(4):349-56. PubMed ID: 23313020
[TBL] [Abstract][Full Text] [Related]
16. Islet amyloidosis in a patient with chronic massive insulin resistance due to antiinsulin receptor antibodies.
O'Brien TD; Rizza RA; Carney JA; Butler PC
J Clin Endocrinol Metab; 1994 Jul; 79(1):290-2. PubMed ID: 8027243
[TBL] [Abstract][Full Text] [Related]
17. [APUD amyloidosis].
Takano K; Ogata E
Nihon Rinsho; 1991 Apr; 49(4):950-5. PubMed ID: 1677052
[No Abstract] [Full Text] [Related]
18. Role of alpha1-acid glycoprotein in therapeutic antifibrotic effects of imatinib with macrolides in mice.
Azuma M; Nishioka Y; Aono Y; Inayama M; Makino H; Kishi J; Shono M; Kinoshita K; Uehara H; Ogushi F; Izumi K; Sone S
Am J Respir Crit Care Med; 2007 Dec; 176(12):1243-50. PubMed ID: 17717205
[TBL] [Abstract][Full Text] [Related]
19. Imatinib mesylate for the treatment of pulmonary arterial hypertension.
ten Freyhaus H; Dumitrescu D; Berghausen E; Vantler M; Caglayan E; Rosenkranz S
Expert Opin Investig Drugs; 2012 Jan; 21(1):119-34. PubMed ID: 22074410
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine kinase inhibitors as novel drugs for the treatment of diabetes.
Prada PO; Saad MJ
Expert Opin Investig Drugs; 2013 Jun; 22(6):751-63. PubMed ID: 23705634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
